See analyst estimates and all valuation multiples for Biopharmaceuticals
Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
---|---|---|---|
$722B | 12.7x | 29.8x | |
$457B | 5.0x | 13.5x | |
$446B | 7.5x | 16.3x | |
$288B | 3.7x | 9.4x | |
$263B | 4.6x | 13.2x | |
$262B | 5.4x | 11.1x | |
$260B | 4.7x | 11.5x | |
$229B | 3.6x | 7.9x | |
$195B | 5.6x | 10.6x | |
$184B | 2.9x | 7.4x | |
$157B | 5.5x | 10.8x | |
$132B | 2.8x | 8.7x | |
$121B | 2.3x | 7.7x | |
$98.1B | 2.3x | 6.8x | |
$95.5B | 8.1x | 23.1x | |
$75.2B | 2.4x | 9.2x | |
$73.1B | 4.6x | 13.8x | |
$70.7B | 7.5x | 17.2x | |
$69.2B | 1.3x | 6.1x | |
$68.1B | 8.3x | 16.3x | |
$63.4B | 2.6x | 9.0x | |
$60.5B | 13.5x | 45.9x | |
$60.5B | 13.5x | 46.1x | |
$52.6B | 5.8x | 19.7x | |
$41.7B | 3.1x | 14.8x | |
$41.4B | 6.7x | 23.5x | |
$36.9B | 2.1x | 7.5x | |
$30.1B | 2.7x | 13.0x | |
$28.5B | 9.8x | 29.3x | |
$27.6B | 1.7x | 7.2x | |
$25.1B | 1.8x | 5.9x | |
$24.9B | 2.6x | 7.7x | |
$24.4B | 1.8x | 8.9x | |
$23.8B | 12.2x | 32.7x | |
$22.4B | 2.2x | 6.5x | |
$21.8B | 7.4x | 7.9x | |
$20.9B | 46.9x | 196.0x | |
$20.3B | 12.7x | 148.5x | |
$18.2B | 2.1x | 8.5x | |
$17.9B | 114.4x | 198.3x | |
$17.9B | 4.0x | 15.5x | |
$15.2B | 5.1x | 13.5x | |
$14.9B | 34.8x | -2026.9x | |
$14.7B | 54.0x | -374.6x | |
$14.4B | 2.5x | 13.8x | |
$14.3B | 4.1x | 10.9x | |
$13.9B | 10.0x | 30.7x | |
$13.4B | 5.0x | 21.3x | |
$13.4B | 3.3x | 12.2x | |
$13.1B | 4.1x | 16.3x | |
$12.8B | 2.2x | 15.5x | |
$12.7B | 8.4x | 32.9x | |
$12.2B | 3.2x | 12.5x | |
$11.8B | 0.3x | 5.4x | |
$11.5B | 3.9x | 10.6x | |
$11.4B | 3.6x | 9.1x | |
$11.3B | 4.1x | 14.4x | |
$11.0B | 5.6x | 17.7x | |
$11.0B | 1.7x | 5.6x | |
$10.8B | 4.0x | 16.4x | |
$10.6B | 2.5x | 6.9x | |
$10.6B | 14.0x | 45.1x | |
$10.5B | 3.2x | 8.0x | |
$10.0B | 1.6x | 12.7x | |
$9.8B | 8.0x | 12.2x | |
$9.5B | 1.8x | 14.0x | |
$9.0B | 28.3x | -631.4x | |
$8.8B | 4.0x | 7.1x | |
$8.7B | n/a | n/a | |
$8.2B | 23.3x | -180.1x | |
$8.2B | n/a | n/a | |
$7.6B | 19.1x | 26.6x | |
$7.2B | 2.0x | 9.5x | |
$7.1B | 4.6x | 23.5x | |
$7.1B | 9.4x | 34.7x | |
$7.0B | 3.0x | 9.2x | |
$6.9B | 3.7x | 17.9x | |
$6.9B | 2.1x | 9.2x | |
$6.6B | 4.2x | 22.0x | |
$6.5B | 3.4x | 14.3x | |
$6.5B | 5.6x | 19.5x | |
$6.3B | n/a | n/a | |
$6.3B | 4.0x | 53.5x | |
$6.3B | 1.5x | 7.9x | |
$6.2B | 7.5x | 33.8x | |
$6.1B | 1.9x | 7.1x | |
$6.1B | 601.8x | -30.2x | |
$6.0B | 18.0x | -61.9x | |
$5.9B | 7.1x | 24.9x | |
$5.8B | 10.5x | 33.7x | |
$5.6B | 1.9x | 8.4x | |
$5.4B | 1.6x | 7.2x | |
$5.2B | 5.6x | 14.3x | |
$5.2B | 11.6x | 39.0x | |
$5.0B | n/a | n/a | |
$5.0B | 1.8x | 4.9x | |
$5.0B | 11.3x | 35.6x | |
$4.8B | n/a | n/a | |
$4.5B | 9.3x | 30.5x | |
$4.3B | 6.4x | n/a | |
$4.2B | 1.7x | 10.0x | |
$4.1B | 12.8x | 82.0x | |
$4.1B | 2.9x | 10.6x | |
$3.9B | 5.8x | 15.0x | |
$3.8B | 35.5x | -1077.0x | |
$3.7B | 7.7x | 17.6x | |
$3.7B | 4.5x | n/a | |
$3.7B | 4.2x | 15.9x | |
$3.6B | 37.6x | -39.0x | |
$3.6B | 5.8x | 16.9x | |
$3.6B | 2.5x | 9.5x | |
$3.4B | 45.8x | -935.2x | |
$3.3B | 17.4x | -73.7x | |
$3.2B | 4.7x | 15.5x | |
$3.1B | 1.5x | 9.9x | |
$3.1B | 2.2x | 8.1x | |
$3.0B | 2.7x | 12.8x | |
$3.0B | n/a | n/a | |
$3.0B | 1.7x | 8.7x | |
$2.9B | 2.3x | 11.4x | |
$2.9B | n/a | n/a | |
$2.9B | 724.4x | -8.5x | |
$2.8B | n/a | n/a | |
$2.8B | 28.4x | -51.5x | |
$2.8B | 7.1x | 21.3x | |
$2.7B | 3.3x | 16.4x | |
$2.6B | n/a | -13.2x | |
$2.5B | n/a | n/a | |
$2.5B | 13.0x | -52.1x | |
$2.5B | 3.3x | 12.6x | |
$2.5B | 6.7x | 15.5x | |
$2.5B | 4.1x | 13.6x | |
$2.5B | 13.3x | 39.3x | |
$2.4B | 3.1x | 17.7x | |
$2.3B | 16.5x | 28.5x | |
$2.3B | 4.0x | 40.1x | |
$2.3B | 6.3x | 17.6x | |
$2.3B | 5.9x | 16.4x | |
$2.2B | n/a | -14.7x | |
$2.1B | 5.8x | -19.6x | |
$2.1B | 6.7x | 12.9x | |
$2.1B | n/a | n/a | |
$2.0B | 56.8x | n/a | |
$2.0B | 14.0x | n/a | |
$2.0B | 2.9x | 11.5x | |
$2.0B | 6.7x | -32.2x | |
$1.9B | 13.0x | 31.5x | |
$1.9B | 0.8x | 5.0x | |
$1.9B | 5.3x | -28.8x | |
$1.9B | 31.2x | n/a | |
$1.8B | 2.9x | 7.1x | |
$1.8B | n/a | n/a | |
$1.8B | 4.3x | n/a | |
$1.8B | 7.9x | 29.6x | |
$1.8B | 6.9x | 27.3x | |
$1.8B | 4.1x | 15.8x | |
$1.7B | 2.4x | 4.0x | |
$1.7B | n/a | n/a | |
$1.7B | 2.3x | 6.2x | |
$1.7B | n/a | -8.0x | |
$1.6B | 2.6x | -91.8x | |
$1.6B | n/a | n/a | |
$1.5B | 4.1x | -103.5x | |
$1.5B | n/a | -7.9x | |
$1.5B | 68.8x | -17.5x | |
$1.5B | 2.4x | 10.2x | |
$1.4B | 19.2x | 33.5x | |
$1.4B | 5.8x | 63.3x | |
$1.4B | 5.4x | n/a | |
$1.4B | 5.4x | 40.9x | |
$1.3B | n/a | -7.1x | |
$1.3B | 1.3x | 5.4x | |
$1.3B | 3.0x | 15.1x | |
$1.2B | 352.2x | n/a | |
$1.2B | 1.9x | -9.1x | |
$1.2B | n/a | n/a | |
$1.2B | 6.5x | 21.9x | |
$1.2B | 0.5x | 4.6x | |
$1.2B | 6.8x | 16.6x | |
$1.2B | 2.5x | 14.8x | |
$1.2B | 10.7x | 305.2x | |
$1.2B | 3.1x | n/a | |
$1.2B | 10.1x | 39.5x | |
$1.2B | 10.8x | 39.5x | |
$1.1B | n/a | n/a | |
$1.0B | 7.2x | -48.2x | |
$996M | 108.0x | -13.8x | |
$986M | 183.9x | n/a | |
$983M | n/a | n/a | |
$976M | 2.9x | 59.2x | |
$965M | n/a | -8.3x | |
$960M | n/a | n/a | |
$942M | n/a | n/a | |
$937M | 8.0x | -14.8x | |
$937M | 3.1x | 3.8x | |
$934M | n/a | n/a | |
$912M | 1.4x | 7.3x | |
$899M | 13.6x | -5.4x | |
$837M | 6.1x | -4.7x | |
$829M | 6.4x | -2.8x | |
$818M | 0.9x | 4.6x | |
$809M | 2.5x | 42.7x | |
$797M | n/a | -3.7x | |
$790M | 16.6x | -8.8x | |
$779M | n/a | -5.3x | |
$775M | 2.2x | 29.2x | |
$765M | 6.7x | -6.9x | |
$762M | n/a | n/a | |
$760M | 1.7x | 8.2x | |
$746M | 61.9x | n/a | |
$741M | 10523.4x | -3.5x | |
$727M | n/a | -8.8x | |
$724M | 739.8x | -7.8x | |
$724M | n/a | n/a | |
$717M | 2.4x | 6.3x | |
$710M | n/a | n/a | |
$702M | 12.9x | n/a | |
$678M | n/a | n/a | |
$675M | n/a | -1.9x | |
$669M | 63.5x | -5.1x | |
$668M | n/a | n/a | |
$668M | 2.5x | 11.2x | |
$661M | 6.3x | 23.2x | |
$660M | 3.2x | n/a | |
$641M | 29.9x | -201.1x | |
$636M | 124605.9x | -5.4x | |
$626M | 229.4x | -2.3x | |
$607M | 3.4x | 16.9x | |
$597M | n/a | -4.3x | |
$594M | 236.9x | -30.4x | |
$566M | 22.8x | n/a | |
$531M | 20.1x | -2.8x | |
$528M | 11.3x | 91.6x | |
$520M | 5.0x | 15.0x | |
$511M | n/a | n/a | |
$510M | 20398.2x | n/a | |
$504M | 1.5x | 5.9x | |
$478M | 1.9x | -1.4x | |
$475M | n/a | -3.7x | |
$472M | 182.0x | -3.5x | |
$456M | n/a | n/a | |
$445M | 1.5x | 11.0x | |
$443M | n/a | n/a | |
$438M | 3.8x | 8.6x | |
$438M | 1.2x | 8.8x | |
$430M | 3.5x | 155.4x | |
$429M | 6.3x | -19.5x | |
$428M | 2.8x | 12.2x | |
$391M | n/a | n/a | |
$373M | 19.5x | 31.9x | |
$368M | 18.7x | -1257.5x | |
$358M | n/a | -2.9x | |
$352M | 6.1x | 23.8x | |
$342M | 1.9x | 8.2x | |
$340M | 5.5x | -4.9x | |
$333M | n/a | -3.0x | |
$330M | 12.8x | -6.1x | |
$322M | n/a | n/a | |
$321M | 0.8x | 6.9x | |
$321M | 4.7x | 31.5x | |
$321M | 3.0x | -4.4x | |
$318M | 8.6x | -2.8x | |
$312M | 6.9x | 29.7x | |
$288M | n/a | -37.5x | |
$285M | n/a | n/a | |
$284M | 2.2x | -1.6x | |
$278M | n/a | n/a | |
$266M | n/a | n/a | |
$266M | 1.9x | -1.6x | |
$262M | n/a | n/a | |
$259M | 26.5x | -1.8x | |
$249M | 5.3x | 18.6x | |
$244M | 45.1x | -6.5x | |
$242M | 3.8x | 8.4x | |
$241M | 6.1x | -23.3x | |
$233M | 3.1x | -6.8x | |
$225M | 14.7x | -5.5x | |
$224M | 11.7x | -10.4x | |
$222M | 1.2x | -2.2x | |
$220M | n/a | -1.4x | |
$220M | n/a | n/a | |
$212M | 9.2x | -5.2x | |
$211M | n/a | n/a | |
$207M | n/a | n/a | |
$201M | 3.1x | n/a | |
$200M | n/a | n/a | |
$196M | n/a | n/a | |
$189M | 2.1x | -7.0x | |
$186M | n/a | -13.1x | |
$186M | 24.4x | -5.9x | |
$185M | 2.3x | 13.6x | |
$179M | 50.1x | -2.6x | |
$175M | n/a | -1.2x | |
$174M | 4.9x | n/a | |
$172M | 1.3x | 14.4x | |
$164M | n/a | n/a | |
$164M | n/a | -1.3x | |
$161M | 29.0x | -13.1x | |
$153M | 13502.8x | -1.6x | |
$152M | 43.1x | -3.5x | |
$152M | 44.7x | -4.8x | |
$148M | 121.3x | -10.4x | |
$147M | n/a | n/a | |
$146M | 15.0x | -3.3x | |
$144M | n/a | n/a | |
$142M | 2.4x | 76.0x | |
$135M | 7.2x | -10.9x | |
$131M | n/a | n/a | |
$127M | 2.2x | n/a | |
$126M | 11.4x | -5.5x | |
$124M | 9.7x | -2.6x | |
$122M | n/a | n/a | |
$119M | 1.9x | 11.2x | |
$111M | n/a | n/a | |
$110M | n/a | -1.1x | |
$107M | 5.4x | 20.2x | |
$104M | n/a | -7.5x | |
$103M | n/a | n/a | |
$97.2M | n/a | -2.1x | |
$96.4M | 3.3x | -1.2x | |
$90.4M | n/a | n/a | |
$90.2M | n/a | n/a | |
$88.3M | n/a | -0.9x | |
$86.1M | n/a | n/a | |
$86.1M | 20.4x | -0.4x | |
$83.1M | n/a | n/a | |
$82.6M | 6.8x | -0.3x | |
$82.0M | 3.3x | 13.1x | |
$81.7M | n/a | n/a | |
$78.1M | n/a | -0.4x | |
$77.6M | 1.5x | n/a | |
$76.3M | 11.0x | -2.5x | |
$76.2M | n/a | n/a | |
$74.1M | 18.8x | -11.6x | |
$71.9M | 10.9x | 8.2x | |
$67.4M | n/a | n/a | |
$66.7M | 5.1x | 13.0x | |
$65.9M | 1.8x | 5.5x | |
$61.6M | n/a | n/a | |
$59.6M | n/a | n/a | |
$56.1M | 11.6x | n/a | |
$55.3M | 13.8x | -0.4x | |
$50.8M | n/a | n/a | |
$49.3M | n/a | n/a | |
$47.2M | n/a | n/a | |
$46.2M | 624.0x | n/a | |
$44.6M | n/a | -2.3x | |
$42.7M | 6.5x | -46.3x | |
$42.4M | 38.4x | -4.5x | |
$41.5M | n/a | n/a | |
$41.1M | 6.1x | n/a | |
$40.9M | 20.1x | -0.2x | |
$38.5M | 6.4x | -4.4x | |
$37.3M | 20.8x | -74.0x | |
$36.6M | 9.4x | n/a | |
$36.6M | n/a | n/a | |
$35.9M | n/a | -2.8x | |
$35.4M | n/a | n/a | |
$35.2M | 1.9x | 43.5x | |
$35.1M | n/a | n/a | |
$34.7M | 65.1x | -2.8x | |
$34.3M | n/a | -7.0x | |
$34.1M | 92.7x | n/a | |
$33.7M | n/a | n/a | |
$33.5M | n/a | n/a | |
$32.4M | n/a | n/a | |
$31.6M | n/a | -8.1x | |
$30.4M | 1.2x | 8.0x | |
$30.2M | 48.6x | -3.2x | |
$29.4M | 8.3x | -6.3x | |
$28.8M | 17.3x | -58.6x | |
$28.3M | 30.5x | -7.3x | |
$27.1M | n/a | n/a | |
$26.9M | n/a | n/a | |
$24.9M | n/a | n/a | |
$23.7M | n/a | -13.2x | |
$22.2M | n/a | n/a | |
$21.6M | 2.3x | -1.5x | |
$21.4M | n/a | n/a | |
$20.9M | n/a | n/a | |
$20.4M | 9.3x | -0.4x | |
$19.8M | n/a | n/a | |
$19.5M | n/a | n/a | |
$19.0M | n/a | -16.2x | |
$19.0M | n/a | n/a | |
$18.9M | n/a | n/a | |
$18.8M | n/a | n/a | |
$17.8M | n/a | n/a | |
$17.5M | 39.1x | -1.8x | |
$17.4M | 0.1x | -0.3x | |
$17.1M | 16.1x | -7.0x | |
$17.1M | 9.2x | -2.2x | |
$17.1M | n/a | n/a | |
$16.5M | n/a | n/a | |
$16.4M | n/a | n/a | |
$16.3M | 2.6x | 8.1x | |
$16.3M | 12.6x | -31.5x | |
$16.2M | n/a | n/a | |
$16.0M | n/a | n/a | |
$15.9M | 8.8x | -1.1x | |
$15.9M | n/a | n/a | |
$15.8M | 2.3x | -15.6x | |
$15.7M | n/a | n/a | |
$15.5M | n/a | n/a | |
$15.0M | 9.6x | n/a | |
$14.7M | n/a | n/a | |
$14.5M | n/a | n/a | |
$14.1M | n/a | n/a | |
$12.6M | n/a | n/a | |
$11.7M | n/a | n/a | |
$11.5M | 0.3x | -0.1x | |
$11.2M | n/a | -3.0x | |
$11.0M | n/a | -5.4x | |
$10.9M | 5.7x | -0.7x | |
$10.3M | n/a | n/a | |
$10.3M | 68.2x | -4.9x | |
$10.3M | 7.6x | -2.4x | |
$9.8M | n/a | n/a | |
$9.4M | 2.5x | -3.0x | |
$9.3M | n/a | n/a | |
$9.1M | n/a | n/a | |
$8.4M | n/a | n/a | |
$7.7M | n/a | -8.3x | |
$7.4M | 14.8x | n/a | |
$7.4M | n/a | n/a | |
$7.3M | n/a | -3.1x | |
$7.3M | n/a | -1.6x | |
$7.1M | 8.9x | -0.6x | |
$6.7M | 31.7x | -2.1x | |
$6.5M | n/a | -1.3x | |
$6.3M | 8.0x | -5.0x | |
$6.1M | n/a | n/a | |
$5.8M | n/a | n/a | |
$5.3M | n/a | n/a | |
$5.1M | n/a | -3.0x | |
$4.4M | n/a | -1.2x | |
$4.4M | n/a | n/a | |
$3.7M | 0.5x | -2.3x | |
$3.6M | n/a | n/a | |
$3.3M | n/a | n/a | |
$3.2M | n/a | n/a | |
$2.6M | n/a | n/a | |
$2.5M | n/a | n/a | |
$2.5M | n/a | n/a | |
$2.1M | n/a | n/a | |
$2.1M | n/a | n/a | |
$2.0M | n/a | n/a | |
$1.9M | 5.8x | -0.6x | |
$1.9M | n/a | 0.5x | |
$1.7M | n/a | n/a | |
$1.5M | n/a | n/a | |
$1.3M | n/a | n/a | |
$1.1M | n/a | n/a | |
$0.9M | n/a | n/a | |
$0.6M | n/a | n/a | |
$0.5M | 0.0x | -0.0x | |
$0.4M | n/a | n/a | |
$0.4M | n/a | n/a | |
$0.2M | n/a | n/a | |
-$0.1M | n/a | n/a | |
-$0.1M | n/a | n/a | |
-$0.1M | -0.2x | n/a | |
-$0.3M | n/a | n/a | |
-$1.9M | -130.2x | 0.2x | |
-$5.0M | n/a | n/a | |
-$6.5M | n/a | n/a | |
-$8.5M | -32.2x | n/a | |
-$8.8M | -3.9x | 0.1x | |
-$13.2M | n/a | n/a | |
-$16.6M | -5.9x | 0.5x | |
-$17.8M | -1.0x | 0.1x | |
-$20.2M | n/a | n/a | |
-$30.7M | -7.2x | n/a | |
-$38.4M | -0.7x | 0.2x | |
-$109M | -60.7x | 0.6x | |
-$113M | -30.9x | 1.3x | |
-$1.5B | -4.4x | 8.2x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Biopharmaceuticals